All lobbying filings

THE PROCTER AND GAMBLE COMPANY

THE PROCTER AND GAMBLE COMPANY filed a Q4 report for THE PROCTER AND GAMBLE COMPANY on January 26, 2026.

Lobbying for THE PROCTER AND GAMBLE COMPANY

All filings by THE PROCTER AND GAMBLE COMPANY · Everything THE PROCTER AND GAMBLE COMPANY has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 26, 2026

Expenses

$527,000

What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 10

Taxation/Internal Revenue Code

-OECD Digital Tax Project (Global Minimum Tax Implementation) -S. 2003 (Strengthening Benefit Plans Act of 2025) -Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions)

Health Issues

-H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. -Issues related to the inclusion of ingredients in over-the-counter products -H.R. 1219, Oral Health Products Inclusion Act

Chemicals/Chemical Industry

- Issues Related to updating the Toxic Substances Control Act (No Bill)

Environment/Superfund

- Issues related to plastics recycling - Issues related to sustainability (no bill) - H.R. 2269/S. 1092 - Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act

Pharmacy

-Issues related to FDA review of active ingredients in over-the-counter products

Trade (domestic/foreign)

- U.S. Manufacturing Policy and the USMCA - Industrial Machinery Section 232 Investigation - Issues related to America First Trade Policy/IEEPA Tariffs Executive Orders - China 301 Tariffs, Export Controls, Sanctions - Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) - Personal Protective Equipment and Medical Equipment Section 232 Investigation - Softwood Lumber Section 232 Investigation - Pharmaceuticals Section 232 Investigation - Semiconductors Section 232 Investigation

Trucking/Shipping

-Issues Related to Gross Vehicle Weight Limits (no bill)

Foreign Relations

-Issues related to Asia-Pacific Economic Cooperation (APEC)

Consumer Issues/Safety/Products

- Issues Related to Product Safety and Quality Assurance (No Bill) - FDA Menstrual Products Guidance

Food Industry (safety, labeling, etc.)

-Issues related to Generally Recognized As Safe designation

Bills named in this filing 6

S. 2003
Strengthening Benefit Plans Act of 2025
H.R. 1
One Big Beautiful Bill Act
H.R. 4273
Over-the-Counter Monograph Drug User Fee Amendments
H.R. 1219
Oral Health Products Inclusion Act
H.R. 2269
To provide for a limitation on availability of funds for US Department of Agriculture, Watershed and Flood Prevention O…
S. 1092
WIPPES Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.